BCLP has an interdisciplinary team of lawyers dedicated to advising trustees, companies, equity sponsors, selling shareholders, management teams, and lenders involved with Employee Stock Ownership Plans (“ESOPs”). 

With respect to our corporate and transactional matters, our team regularly advises clients in the utilization of ESOPs for shareholder liquidity, including the creation and implementation of ESOPs, the sale of stock to ESOPs (both partial sales and complete change of control transactions), the sale of ESOP-owned companies to strategic and financial buyers, the utilization of ESOPs as a means of affecting bolt-on transactions, and mergers and acquisitions of ESOP companies.  In connection with corporate transactions, we regularly advise clients in Section 1042 transactions and S corporation tax structuring. 

Regarding lending matters, our team also regularly counsels lenders and ESOP-owned companies with respect to ESOP acquisition financing and ordinary-course financings for ESOP companies.  In this capacity, we have a deep understanding of both the ordinary-course lending and corporate finance matters presented in various lending structures, as well as the nuances involved in lending to ESOP-owned companies (including the unique funds flow and financial covenant issues presented with such loans).

With respect to litigation and corporate risk, our litigators represent ESOP trustees, corporate fiduciaries, selling shareholders and plan sponsors in disputes relating to alleged breaches of fiduciary duty and other violations of ERISA.  We also regularly guide ESOP trustees, corporate fiduciaries, and plan sponsors through investigations by the Department of Labor and other governmental agencies.

As a result of our broad-based ESOP practice, we have an unparalleled depth of knowledge advising trustees, shareholders, lenders, and boards of directors on fiduciary and governance-related issues confronting fiduciaries and ESOP-owned companies.  In this capacity, our team regularly advises stakeholders within the ESOP ecosystem on contentious and day-to-day operational, governance, and finance related issues.

Our team is often published in journals and regularly presents to professional and business groups regarding the use of ESOPs in areas such as succession planning, leveraged buyouts and M&A transactions. 

Recent Representative Corporate and Transactional Matters:

• Represented a 100% ESOP-owned, Houston based industrial distribution company in connection with its sale to a publicly traded strategic acquiror and related retention bonus arrangements.
• Represented a Georgia-based specialty building manufacturer in connection with its implementation of an ESOP, subsequent merger with a 100% ESOP-owned strategic acquiror, and related acquisition financing and 1042 transactions.
• Represented a U.S.-based leading manufacturer of private label personal care products in connection with a management buy-out via ESOP, including the private placement of notes and warrants to partially fund the transaction, pursuant to which the company was sold to a newly created ESOP, with the management team retaining warrants and synthetic equity, and related acquisition financing.
• Represented a national medical practice in connection with its establishment of a management services organization, recapitalization, partial sale to a newly formed ESOP, and related acquisition financing.
• Represented a California-based online product marketing company in connection with its recapitalization, second-stage ESOP sale, and related acquisition financing.
• Represented an Ohio-based advanced materials manufacturer in connection with its acquisition of an ESOP-owned manufacturer of cemented tungsten carbide solutions.
• Represented a California-based technology and professional staffing company with respect to its spin-out of select technology assets, partial sale to a newly created ESOP, subsequent second-stage ESOP transaction, and related financing transactions.
• Represented a Chicago-based family construction and construction management company in the implementation of a staged ESOP strategy to create shareholder liquidity.
• Represented a Colorado-based, multistate free company that owned and operated free-standing radiological centers in the implementation of an ESOP, the spin-off of select assets and business lines, the sale of stock to the newly formed ESOP, and related acquisition financing and 1042 transactions.
• Represented an institutional ESOP trustee in connection with the partial redemption and acquisition of the remaining stock of an Ohio-based custom molding supplier to the automotive industry.
• Represented the institutional trustee of an ESOP with regard to the acquisition of 100% of the stock of a New York-based infrastructure construction and engineering company.
• Represented a North Carolina technology company in the government contracting verticle in the establishment of a contributory ESOP and with related issues involving Tribal ownership.
• Represented a selling shareholder of a Florida-based marketing company in restructuring of an S corporation to allow for the sale of seller warrants to a potential strategic investor without breaking the ESOP-owned entity’s S corporation status.
• Represented the selling shareholders of a New York-based streaming company on a post-transaction restructuring to avoid potential claims resulting from a brief downturn in business following a large partial ESOP transaction.
• Represented the institutional trustee of an ESOP with regard to the merger of a partially ESOP-owned Southeastern-based insurance brokerage with and into a publicly traded strategic acquiror.
• Represented the trustee of an ESOP with regard to the sale of stock of a Cincinnati-based mechanical contractor.
• Represented the institutional trustee of an ESOP with regard to the sale of stock of a partially ESOP-owned Montana-based civil engineering firm, resulting in a 100% ESOP-owned company.
• Represented the institutional trustee of an ESOP with regard to the sale of stock of an Atlanta-based construction management and civil engineering firm to a newly formed ESOP.
• Served as special counsel to a European multi-national corporation purchasing the stock of a U.S. corporation from an ESOP.
• Developed an independent fiduciary mechanism for a transaction, in which assets from our client’s ESOP were transferred to the retirement plan of the purchaser.
• Represented the institutional trustee of an ESOP with regard to the sale of stock of a defense engineering and contract business to a foreign public company.

Recent Representative Litigation and Corporate Risk Matters:

• Represented several ESOP clients in Department of Labor investigations and averted DOL prosecutions.
• Successfully represented an ESOP trustee against claims for benefits and accompanying allegations of fiduciary breach.
• Represented an independent ESOP fiduciary against claims for professional malpractice and fiduciary breach.
• Obtained summary judgment for a company-sponsored ESOP and its trustees on claims for violation of ERISA’s Anti-Cutback and Significant Detriment Rules.

Recent Representative Lending Matters:

• Represented lender in connection with $12,500,000 credit facility to finance the sale of stock to a newly formed ESOP for a construction company.
• Represented lender in connection with $40,000,000 credit facility to finance the sale of stock to a newly formed ESOP for a mechanical contracting company.
• Represented large nonbank lender as special ESOP counsel in connection with a partial sale of a large accounting company to an ESOP.

For additional information on BCLP’s ESOP practice please contact Steve Schaffer (Group Leader), Robert Lystad (Corporate Transactions), Bard Brockman  (Litigation and Corporate Risk), or Cass Hollis (Fiduciary and Lending).